GOSS - Gossamer Bio Director Awarded $165K Worth of Stock Options | Benzinga
John Quisel, Director at Gossamer Bio (NASDAQ:GOSS), reported a large acquisition of company stock options on November 29, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Quisel, Director at Gossamer Bio, a company in the Health Care sector, was just awarded stock options worth 230,000 shares of GOSS. The options give Quisel the right to buy the company's stock at $0.69 per share.
Gossamer Bio shares are trading down 0.0% at $0.72 at the time of this writing on Thursday morning. Since the current price is $0.72, this makes Quisel's 230,000 shares worth $165,531.